Amlodipine Besilate for Suspension(Guangzhou Yipinhong Pharma)

苯磺酸氨氯地平干混悬剂（广州一品红制药）

Report date: 2025/07/10 10:37:26

Base Information

Drug NameAmlodipine Besilate for Suspension(Guangzhou Yipinhong Pharma)
Drug Alias Nameamlodipine苯磺酸氨氯地平干混悬剂（2.2类改良型）amlodipino苯甲酸氨氯地平干混悬剂（2.2类改良型）amlodipinum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionCoronary DiseaseAngina, Stable +[4] 
Global Approved IndicationsHypertensionCoronary DiseaseAngina, Stable +[4] 
Approved Indications in ChinaHypertensionCoronary DiseaseAngina, Stable +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date2024/01/16
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangzhou Yipinhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Yipinhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionCoronary DiseaseAngina, Stable +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG